adaapablogsi.blogspot.com
W. Fraser Symmans, MD
The American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) have further refined their recommendations for estrogen receptor (ER) and progesterone receptor (PgR) testing protocols in patients with breast cancer. The latest update offers guidance for interpreting a new reporting category— ER-low–positive cancers, which are defined as breast cancer samples with 1% to 10% of tumor nuclei staining positive for ER (
Table 1).
1
... to read the full story
Let's block ads! (Why?)
"breast" - Google News
May 04, 2020 at 09:47PM
https://ift.tt/3da0HAE
Breast Cancer Guidelines Carve Out Category for Low ER Expression - OncLive
"breast" - Google News
https://ift.tt/2ImtPYC
https://ift.tt/2Wle22m
Bagikan Berita Ini
0 Response to "Breast Cancer Guidelines Carve Out Category for Low ER Expression - OncLive"
Post a Comment